Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)

NCT02947438 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Anemia

Interventions

DRUG: EPREX®
DRUG: EPIAO®

Sponsor

Shenyang Sunshine Pharmaceutical Co., LTD.

Collaborators

[object Object]